ÂÜÀòÂÒÂ×

Tomas Kramar is a founding partner at Kramar Group since June 2019, demonstrating leadership in various organizations. Currently serving as a board member for Nanologica AB, SpectraCure AB, Corsmed, and Deep Light Vision AB, Kramar also holds the position of chairperson for Cardeon AB and the Percy Falk Foundation. With extensive involvement in Lundonia Biotech AB and a prior role as a board member for Gentian Diagnostics AS until May 2023, Kramar's leadership experience is complemented by a tenure as CEO of Siemens Healthineers in Sweden from October 2015 to August 2019. Kramar earned a Master of Science degree in Chemistry from The Faculty of Engineering at Lund University between 1973 and 1979.